|
News
06.01. 2007
M-Biotech expanded business sector
to personalized medicine based on the filed patent.
03.01. 2007
Co-work with University of Utah team
to develop M-Biotech’s glucose biosensor system using MEMS.
02.05.2005
The Annual Meeting of shareholders was held at the
M-Biotech offices in Sandy, Utah.
08.15.2004
M-Biotech presented “Hydrogels for Non-Enzymatic
Glucose Biosensors” at the 17th Polymer Networks Group
Meeting in Bethesda, Maryland.
08.09.2004
M-Biotech was granted research funding from USAMRMC Military Operational
Medicine Research
Program.
12.01.2003
The 2003 Annual Meeting of the shareholders of M-Biotech was on
December 29 at 1:00 p.m. The meeting was
held at the new corporate offices located at 576 West 8360 South, Sandy, Utah 84070.
11.07.2003
M-Biotech presented at the Third Annual Diabetes
Technology Meeting in San Francisco, CA.
10.27.2003
M-Biotech introduced its hydrogel glucose biosensor
technology at the 2003 Annual AAPS Meeting in Salt Lake City, Utah.
10.15.2003
M-Biotech’s hydrogel technology was presented at
the First World Congress on Synthetic Receptors 2003 in Lisbon, Portugal.
09.23.2003
Animal
proof-of-concept announced. M-Biotech, Inc., a leading developer of
proprietary implantable glucose monitors and Hydrogel based biosensors,
announced today that recent successful animal studies conducted by the Company
show proof-of-concept in animals for the Company’s continuous
monitor implant.
This milestone brings us one step closer to the
goal of developing a critically needed way of monitoring the glucose
levels of diabetes patients to improve their quality of life. We look forward to accelerating the
development of this innovative medical device upon completion of our next
round of financing.
09.15.2003
Patient Care Archives introduced M-Biotech’s implantable glucose
sensor under the article of New
technologies in diabetes care in their September 2003 issue.
04.07.2003
Defeat
Diabetes introduced M-Biotech’s patent.
03.17.2003
Medical
Industry Week, the UK based
business journal(www.espicom.com),
introduced M-Biotech's new patent for hydrogel technology in its March 17, 2003 issue
(p 27, issue 217).
03.01.2003
Startup
Magazine profiles M-Biotech in their March 2003 issue.
02.27.2003
M-Biotech presents at the Medtech Insight Conference, "Investment In
Innovation: A Preview of Early-Stage Medical Device Companies"
in Irvine, CA.
02.14.2003
M-Biotech presents "A Continuously Measurable
Glucose Biosensor Based on Competitive Binding in a Glucose-Sensitive
Hydrogel," at the Second La Jolla Conference On Glucose Monitoring
And Control.
02.04.2003
M-Biotech's Patent Entitled, "Hydrogel
Biosensor" Is Issued (Patent No. 6,514,689) By The U.S. Patent And Trademark Office. View
Patent.
12.01.2002
M-Biotech names Mark Nocerini as Chief Technology
Officer. Mr. Nocerini has extensive experience in the pharmaceutical
industry.
11.11.2002
M-Biotech's Article Entitled "Constant-Volume
Hydrogel Osmometer: A New Device Concept For Miniature Biosensors"
Published In Biomacromolecules (Volume 3, Issue 6, pp1271-1275).
11.05.2002
M-Biotech's Patent Entitled, "Glucose
Biosensor" Is Issued (Patent No. 6,475,750) By The U.S. Patent And Trademark Office. View
Patent.
10.31.2002
M-Biotech Presents Poster At The Second Annual Diabetes
Technology Meeting in Atlanta, Georgia.
09.09.2002
M-Biotech Receives "Notice of Allowance" For
Patent Application Entitled, "Hydrogel Biosensor" (US 09/839,993) From The U.S. Patent And Trademark Office. View
Patent Application, (Use Patent Application Number 20020042065 to
search).
08.26.2002
M-Biotech Announces New Product: Hydrogel
Swelling Kinetics Monitoring System, A Powerful Tool For
Evaluating The Characteristics Of Hydrogel In A Precise And
Time-efficient Manner. This System Is Based On M-Biotech's Patented Pressure Biosensor Technology.
07.26.2002
Clinica World Medical Device & Diagnostic News
announces, "Early results back M-Biotech's implantable glucose
monitor" in their July 26, 2002 newsletter (issue 1017, p 29).
06.27.2002
M-Biotech presents at the Medtech Insight Conference
"Investment In Innovation: A Preview of Early-Stage Medical Device
Companies" in San Francisco, CA. See Press Release.
06.20.2002
M-Biotech presents at the Investors Choice
International Equity Capital Conference in Maui, Hawaii.
11.01.2001
M-Biotech recieves a World Patent entitled: Hydrogel
Biosensor and Biosensor-based Health Alarm System. Patent number WO
01/81890 A2.
10.11.2001
M-Biotech recieves World Patent number WO 01/75089 A1.
10.03.2001
- 10.05.2001
M-Biotech exhibits at Medical Records Institute's
Wireless Healthcare Applications & Technology Conference in Las Vegas, NV.
07.31.2001
M-Biotech's Patent Entitled, "Glucose
Biosensor" Is Issued (Patent No. 6,268,161) By The U.S. Patent And Trademark Office. View
Patent.
04.04.2001
M-Biotech's glucose biosensor has been granted a World
Patent (WO 01/16575 A1).
09.21.2000
M-Biotech Inc. has extended the contract research with
Dr. Magda from the University of Utah until September 1, 2001.
08.23.2000
M-Biotech Inc. Acquired European Patent Entitled
“Biosensor” (EP1029229).
08.17.2000
M-Biotech Inc. Signs Financing and Licensing Agreement
with Chong Kun Dang Pharmaceuticals.
M-Biotech Inc. and Chong Kun Dang Pharmaceutical Corp.
of Korea recently completed a financing
and licensing agreement in Seoul, Korea. The agreement provides $1
Million in financing to M-Biotech, and grants an exclusive license in Asia to Chong Kun Dang for an
implantable glucose biosensor being developed by M-Biotech.
04.10.2000
Publication in Macromolecules, Volume 33, Number 9,
Pages 3332-3336; “Catalase Effects on Glucose-Sensitive
Hydrogels”.
05.01.1999
Granted Small Business Innovative Research (SBIR) Phase
I (R43DK55958) from NIH, titled, “Implantable Glucose
Biosensor”.
|
